Specify a stock or a cryptocurrency in the search bar to get a summary
China Shineway Pharmaceutical Group Ltd
CSWYYChina Shineway Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and trade of Chinese medicines in the People's Republic of China and Hong Kong. The company offers Chinese medicines in the form of injection, soft capsules, and granules; tablets, pills, oral liquid, and powder; and traditional Chinese medicine granules in various therapeutic areas, including respiratory system disease, nervous system, digestive system disease, cardiovascular and cerebrovascular, orthopedics, pediatrics, and other areas, as well as medication for strengthening the body. It is also involved in the trading of agricultural products; and research and development of Chinese pharmaceutical products. The company was incorporated in 2002 and is headquartered in Shijiazhuang, the People's Republic of China. China Shineway Pharmaceutical Group Limited operates as a subsidiary of BH Corporate Services Ltd. Address: No. 168, Shiluan Street, Shijiazhuang, China, 051430
Analytics
WallStreet Target Price
115.73 HKDP/E ratio
4.9689Dividend Yield
7.21 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures CSWYY
Dividend Analytics CSWYY
Dividend growth over 5 years
71 %Continuous growth
2 yearsPayout Ratio 5 years average
59 %Dividend History CSWYY
Stock Valuation CSWYY
Financials CSWYY
Results | 2019 | Dynamics |